Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · View financials
Decision snapshot: CHKP stock price vs MOH: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at MOH's multiple
Needs MOH P/E.
Implied fair value · at CHKP's multiple
Needs CHKP P/E.
Live quote
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: CHKP FY 2025 (ended Dec 31, 2025) · MOH FY 2025 (ended Dec 31, 2025).
Trendline
Ten fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
CHECK POINT SOFTWARE TECHNOLOGIES LTD. · implied price per share
Bear
$44.43
Base
$52.28
Bull
$60.12
MOLINA HEALTHCARE, INC. · implied price per share
Bear
-$133.88
Base
-$157.51
Bull
-$181.14
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
1.68x
0.93x
Net debt / EBITDA
Leverage against operating earnings
2.99x
-4.56x
Cash and equivalents
Liquid reserves on the balance sheet
$1.80B
$8.26B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
$4.83B
$3.78B
Live quote
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
Based on an earlier data snapshot. Review the filing dates below or refresh after signing in.
If you believe CHKP can sustain its high margins and defend its 14.1% ROIC despite only moderate growth, then CHKP looks attractive relative to MOH because the stock is cheaper on P/E while the business quality gap is large.
CHKP trades at 14.4x P/E versus MOH at 20.1x, yet CHKP also has far superior margins and returns, making the valuation gap look favorable on a quality-adjusted basis. CHKP’s current price of $138.15 is below the implied $193.22 P/E-based value and sits within its historical band, but still well above the DCF range, so the upside case depends on multiple support rather than discounted cash flow.
Supporting Metrics
